Building an In-House Cell and Gene Therapy Manufacturing Facility during the Pandemic

Building an In-House Cell and Gene Therapy Manufacturing Facility during the Pandemic
The impact and disruption caused by the COVID-19 pandemic added an unprecedented level of risk and complexity for companies like Expression Therapeutics who were in the midst of constructing a new manufacturing facility. By taking a flexible project execution approach including pre-fabricated cleanrooms, the company was able to adapt to the situation and overcome the challenges ultimately resulting in the successful completion of the project on time and under budget. The project case study will be presented.